Skip to main content

Confluent Medical Technologies Announces REACH and EU MDR Compliant Polyimide Tubing

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CHATTANOOGA, Tenn., June 12, 2023 (GLOBE NEWSWIRE) -- Confluent Medical Technologies (Confluent), a leading medical device and materials science contract manufacturer specializing in high-precision polymer tubing, today announced the offering of REACH and EU Medical Device Regulation (MDR) Compliant Polyimide Tubing.

REACH, an acronym for Registration, Evaluation, Authorization, and Restriction of Chemicals, is an EU regulation that imposes stringent limitations on the amount of restricted substances that can be contained in devices sold in the EU. The industry standard polyimide, a material used extensively in medical applications such as vascular catheters, contains one of the restricted solvents.

“Historically, ensuring REACH compliance required extensive post processing to remove the residual solvent and even after this processing, compliance is not guaranteed,” stated Jill Ellison, VP of Site Operations for Confluent’s Polymer Tubing Center of Excellence. “Confluent’s REACH Compliant Polyimide is made with no restricted substances, therefore, there are no restricted solvents to remove and no extensive and expensive testing is required.”

Confluent’s REACH Compliant Polyimide uses industry standard chemistry resulting in product that looks and performs like traditional polyimide while avoiding the historical hurdles of ensuring EU compliance. Confluent is offering their REACH Compliant Polyimide immediately with lead times of 4 weeks or less.

About Confluent Medical

Confluent Applies Materials Science to MedTech Innovation. Confluent specializes in the expert design, development, and large-scale manufacturing of interventional catheter-based devices and implants. Customers rely on Confluent’s expertise in Nitinol material and components, balloon and complex catheters, high-precision polymer tubing, and implantable textiles. With facilities in Fremont and Orange County, California; Warwick, Rhode Island; Windham, Maine; Austin, Texas; Chattanooga, Tennessee; and San Jose, Costa Rica, Confluent has earned the confidence of the leaders in the medical device community through a proven track record of innovative materials science, engineering, and manufacturing. For more information, visit confluentmedical.com.

Media

Brittany Mai
Brittany.mai@confluentmedial.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/56fe1de6-05ce-4cdd-8e28-16006a385e37


Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  272.97
+1.80 (0.66%)
AAPL  292.76
+5.32 (1.85%)
AMD  439.28
+30.82 (7.55%)
BAC  51.69
-1.06 (-2.02%)
GOOG  395.91
+0.61 (0.15%)
META  607.42
-9.39 (-1.52%)
MSFT  416.72
-4.05 (-0.96%)
NVDA  216.25
+4.75 (2.25%)
ORCL  196.75
+2.16 (1.11%)
TSLA  429.62
+17.83 (4.33%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.